GLP-1 / GIP / GLUCAGON TRIPLE AGONIST
Buy retatrutide — 10, 20 & 30 mg, 99%+ purity, COA per batch
Lab-grade retatrutide (an analogue of Eli Lilly's LY3437943) supplied as a lyophilised powder. HPLC-verified, cold-chain shipped from our lab in België, with a Certificate of Analysis available on request for every batch.
What is retatrutide?
Retatrutide (research code LY3437943) is a synthetic peptide developed by Eli Lilly as a next-generation incretin mimetic. Unlike semaglutide (Ozempic) or tirzepatide (Mounjaro), retatrutide acts as a triple agonist: it binds simultaneously to GLP-1, GIP and glucagon receptors.
In phase II clinical trials published in NEJM (2023), 48 weeks of retatrutide in patients with obesity led to an average weight loss of 24%. Retatrutide is currently in phase III clinical trials. Important: these studies concern Eli Lilly's clinical candidate molecule (LY3437943) administered to humans in a controlled research setting — the Peptica lab product is intended exclusively for in-vitro and preclinical research and is not for human use.
Product specifications
Source for molecular weight and CAS number: PubChem — Retatrutide (CID 156588324).
Reconstitution & dosing
A 20 mg vial reconstituted with 2 ml of bacteriostatic water gives a concentration of 10 mg/ml. Use our peptide calculator to convert any mark on an insulin syringe to exact micrograms.
Open the peptide calculatorLab report & batch verification
Every batch of retatrutide is independently analysed via HPLC and mass spectrometry. The Certificate of Analysis (COA) can be requested per batch ID by email and lists purity, MW confirmation and residual solvents.
View all lab resultsResearch & studies
Frequently asked questions about retatrutide
For more scientific background, specifications and studies, see our retatrutide research page.
Ready to order retatrutide?
10, 20 and 30 mg vials, COA per batch, cold-chain shipped from België — usually delivered the next working day. Note: only a few 10 mg vials remain.
Order retatrutide